Tilray Brands Inc
NASDAQ: TLRY
$2.10
+$0.08 (+4.0%)
Closing price May 3, 2024
TLRY Articles
In addition to rising hopes for a change in U.S. law removing marijuana from a list of dangerous drugs, a swarm of retail investors has been taking aim at pot stock short sellers. Here's how that's...
Published:
Tilray shares jumped on Tuesday after the company announced that it would be expanding its operations into the United Kingdom.
Published:
Marijuana growers Aphria and Tilray have announced a reverse merger that will create the world's largest cannabis company measured by revenue.
Published:
Large marijuana stocks have risen sharply since the U.S. elections early in November. The increase is not based so much on the results as on what could happen next.
Published:
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Chewy, DraftKings, Exxon Mobil, McAfee, Nvidia, Square, Tilray and Walt Disney.
Published:
Marijuana stocks got hammered on Wednesday but came roaring back Thursday. What changed?
Published:
24/7 Wall St. has tracked a group of companies that have simply refused to participate in the stock market upside.
Published:
Canadian cannabis grower and products maker Aurora Cannabis posted a much larger-than-expected full-year net loss after markets closed Tuesday.
Published:
Monday’s top analyst upgrades and downgrades included ADP Automatic Data Processing, Carrier Global, Darden Restaurants, KLA, Lam Research, Oracle, Snowflake, Southern, Tilray, UPS and Visa.
Published:
A recent final ruling from the U.S. Drug Enforcement Administration has cast doubt on the legality of some non-psychoactive products derived from the hemp.
Published:
Tilray reported disappointing quarterly results after the market closed on Monday, and many analysts took to the sidelines.
Published:
Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability. In the United States, high state and...
Published:
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
Published:
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
Published:
High times in hard times? Tilray says pot should be seen as a consumer staple rather than an indulgence.
Published: